COVID - 19
167
12
21
94
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
11 trials with published results (7%)
Research Maturity
94 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
6 terminated out of 167 trials
94.0%
+7.5% vs benchmark
7%
12 trials in Phase 3/4
12%
11 of 94 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 94 completed trials
Clinical Trials (167)
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory Infections
A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults
Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function
Dapagliflozin for Long COVID Syndrome
French Single Centre Experience of Critically Ill Patients With Covid 19
Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France
Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority
Retail COVID-19 Study
Diagnostic Accuracy of 2 cm Versus 4 cm Insertion Depth for Nasal Swabs for SARS-CoV-2 (COVID-19) Rapid Antigen Testing-A Randomized Controlled Trial
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period
Development of Preterm Infants Born During the COVID-19 Pandemic
Effect of Pulmonary Rehabilitation and Physical Activity on COVID-19 Long-Term Symptoms (PuReCOVID)
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
PA-001 Ph.1 Study in Healthy and Elderly Subjects
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19